High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
J Anal Toxicol February 16, 2014 DOI: 10.1093/jat/bku005 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractA method using high-performance liquid chromatography with tandem mass spectrometry was developed and validated to detect and quantify nine hallucinogenic 25-NBOMe designer drugs in urine specimens. The technique provides a reliable analytical tool for forensic and clinical toxicology laboratories to identify these potent substances in biological samples.
Study at a glance
| Characteristics | Method development and validation study Peer reviewed |
|---|---|
| Key finding | A validated LC-MS/MS method can accurately determine nine 25-NBOMe drugs in urine. |
Abstract
High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.